» Articles » PMID: 36952330

Effect of Cross-Seeding of Wild-Type Amyloid-β Peptides with Post-translationally Modified Fibrils on Internal Dynamics of the Fibrils Using Deuterium Solid-State NMR

Overview
Journal J Phys Chem B
Specialty Chemistry
Date 2023 Mar 23
PMID 36952330
Authors
Affiliations
Soon will be listed here.
Abstract

Post-translationally modified (PTM) amyloid-β (Aβ) species can play an important role in modulating Alzheimer's disease pathology. These relatively less populated modifications can cross-seed the wild-type Aβ peptides to produce fibrils that retain many structural and functional features of the original PTM variants. We focus on studies of internal flexibility in the cross-seeded Aβ fibrils originating from seeding with two PTM variants with modifications in the disordered N-terminal domain: Δ3 truncation and S8-phosphorylation. We employ an array of H solid-state NMR techniques, including line shape analysis over a broad temperature range, longitudinal relaxation, and quadrupolar CPMG, to assess the dynamics of the cross-seeded fibrils. The focus is placed on selected side-chain sites in the disordered N-terminal domain (G9 and V12) and hydrophobic core methyl and aromatic groups (L17, L34, M35, V36, and F19). We find that many of the essential features of the dynamics present in the original PTM seeds persist in the cross-seeded fibrils, and several of the characteristic features are even enhanced. This is particularly true for the activation energies of the rotameric motions and large-scale rearrangements of the N-terminal domain. Thus, our results on the dynamics complement prior structural and cell toxicity studies, suggesting that many PTM Aβ species can aggressively cross-seed the wild-type peptide in a manner that propagates the PTM's signature.

Citing Articles

Rigidifying of the internal dynamics of amyloid-beta fibrils generated in the presence of synaptic plasma vesicles.

Vugmeyster L, Au D, Frazier B, Qiang W, Ostrovsky D Phys Chem Chem Phys. 2024; 26(6):5466-5478.

PMID: 38277177 PMC: 10956644. DOI: 10.1039/d3cp04824a.


In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer's Disease.

Tettevi E, Kuevi D, Sumabe B, Simpong D, Maina M, Dongdem J Biomed Res Int. 2024; 2024:9985719.

PMID: 38221912 PMC: 10787656. DOI: 10.1155/2024/9985719.

References
1.
Au D, Ostrovsky D, Fu R, Vugmeyster L . Solid-state NMR reveals a comprehensive view of the dynamics of the flexible, disordered N-terminal domain of amyloid-β fibrils. J Biol Chem. 2019; 294(15):5840-5853. PMC: 6463690. DOI: 10.1074/jbc.RA118.006559. View

2.
Barykin E, Mitkevich V, Kozin S, Makarov A . Amyloid β Modification: A Key to the Sporadic Alzheimer's Disease?. Front Genet. 2017; 8:58. PMC: 5430028. DOI: 10.3389/fgene.2017.00058. View

3.
Hu Z, Cruceta L, Zhang S, Sun Y, Qiang W . Cross-Seeded Fibrillation Induced by Pyroglutamate-3 and Truncated Aβ Variants Leads to Aβ Structural Polymorphism Modulation and Elevated Toxicity. ACS Chem Neurosci. 2021; 12(19):3625-3637. DOI: 10.1021/acschemneuro.1c00341. View

4.
Petkova A, Yau W, Tycko R . Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry. 2006; 45(2):498-512. PMC: 1435828. DOI: 10.1021/bi051952q. View

5.
Pauwels K, Williams T, Morris K, Jonckheere W, Vandersteen A, Kelly G . Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease. J Biol Chem. 2011; 287(8):5650-60. PMC: 3285338. DOI: 10.1074/jbc.M111.264473. View